158 related articles for article (PubMed ID: 25193095)
1. Self-aggregated nanoparticles of carboxylic curdlan-deoxycholic acid conjugates as a carrier of doxorubicin.
Yan JK; Ma HL; Chen X; Pei JJ; Wang ZB; Wu JY
Int J Biol Macromol; 2015 Jan; 72():333-40. PubMed ID: 25193095
[TBL] [Abstract][Full Text] [Related]
2. pH-sensitive chitosan-derived nanoparticles as doxorubicin carriers for effective anti-tumor activity: preparation and in vitro evaluation.
Jin YH; Hu HY; Qiao MX; Zhu J; Qi JW; Hu CJ; Zhang Q; Chen DW
Colloids Surf B Biointerfaces; 2012 Jun; 94():184-91. PubMed ID: 22405470
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and characterization of amphiphilic glycidol-chitosan-deoxycholic acid nanoparticles as a drug carrier for doxorubicin.
Zhou H; Yu W; Guo X; Liu X; Li N; Zhang Y; Ma X
Biomacromolecules; 2010 Dec; 11(12):3480-6. PubMed ID: 21028798
[TBL] [Abstract][Full Text] [Related]
4. Deoxycholic acid modified-carboxymethyl curdlan conjugate as a novel carrier of epirubicin: in vitro and in vivo studies.
Gao F; Li L; Zhang H; Yang W; Chen H; Zhou J; Zhou Z; Wang Y; Cai Y; Li X; Liu L; Zhang Q
Int J Pharm; 2010 Jun; 392(1-2):254-60. PubMed ID: 20347028
[TBL] [Abstract][Full Text] [Related]
5. Bile acid-conjugated chondroitin sulfate A-based nanoparticles for tumor-targeted anticancer drug delivery.
Lee JY; Chung SJ; Cho HJ; Kim DD
Eur J Pharm Biopharm; 2015 Aug; 94():532-41. PubMed ID: 26149228
[TBL] [Abstract][Full Text] [Related]
6. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.
Zhang J; Chen XG; Li YY; Liu CS
Nanomedicine; 2007 Dec; 3(4):258-65. PubMed ID: 17962086
[TBL] [Abstract][Full Text] [Related]
7. In vitro investigation of self-assembled nanoparticles based on hyaluronic acid-deoxycholic acid conjugates for controlled release doxorubicin: effect of degree of substitution of deoxycholic acid.
Wei WH; Dong XM; Liu CG
Int J Mol Sci; 2015 Mar; 16(4):7195-209. PubMed ID: 25837468
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin release from self-assembled nanoparticles of deoxycholic acid-conjugated dextran.
Jeong YI; Chung KD; Choi KC
Arch Pharm Res; 2011 Jan; 34(1):159-67. PubMed ID: 21468928
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles of deoxycholic acid, polyethylene glycol and folic acid-modified chitosan for targeted delivery of doxorubicin.
Shi Z; Guo R; Li W; Zhang Y; Xue W; Tang Y; Zhang Y
J Mater Sci Mater Med; 2014 Mar; 25(3):723-31. PubMed ID: 24327111
[TBL] [Abstract][Full Text] [Related]
10. Self-assembled nanoparticles based on chondroitin sulfate-deoxycholic acid conjugates for docetaxel delivery: Effect of degree of substitution of deoxycholic acid.
Liu M; Du H; Zhai G
Colloids Surf B Biointerfaces; 2016 Oct; 146():235-44. PubMed ID: 27343846
[TBL] [Abstract][Full Text] [Related]
11. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
Yu JM; Li YJ; Qiu LY; Jin Y
J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
[TBL] [Abstract][Full Text] [Related]
12. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.
Hwang HY; Kim IS; Kwon IC; Kim YH
J Control Release; 2008 May; 128(1):23-31. PubMed ID: 18374444
[TBL] [Abstract][Full Text] [Related]
13. Effect of molecular weight on the oleoyl-chitosan nanoparticles as carriers for doxorubicin.
Zhang J; Chen XG; Sun GZ; Huang L; Cheng XJ
Colloids Surf B Biointerfaces; 2010 Jun; 77(2):125-30. PubMed ID: 20172698
[TBL] [Abstract][Full Text] [Related]
14. Functionalized nanoscale β-1,3-glucan to improve Her2+ breast cancer therapy: In vitro and in vivo study.
Nasrollahi Z; Mohammadi SR; Mollarazi E; Yadegari MH; Hassan ZM; Talaei F; Dinarvand R; Akbari H; Atyabi F
J Control Release; 2015 Mar; 202():49-56. PubMed ID: 25597638
[TBL] [Abstract][Full Text] [Related]
15. Bioreducible carboxymethyl dextran nanoparticles for tumor-targeted drug delivery.
Thambi T; You DG; Han HS; Deepagan VG; Jeon SM; Suh YD; Choi KY; Kim K; Kwon IC; Yi GR; Lee JY; Lee DS; Park JH
Adv Healthc Mater; 2014 Nov; 3(11):1829-38. PubMed ID: 24753360
[TBL] [Abstract][Full Text] [Related]
16. Cationic nanoparticles self-assembled from amphiphilic chitosan derivatives containing poly(amidoamine) dendrons and deoxycholic acid as a vector for co-delivery of doxorubicin and gene.
Chen S; Deng J; Zhang LM
Carbohydr Polym; 2021 Apr; 258():117706. PubMed ID: 33593576
[TBL] [Abstract][Full Text] [Related]
17. Tumor targeting efficiency of bare nanoparticles does not mean the efficacy of loaded anticancer drugs: importance of radionuclide imaging for optimization of highly selective tumor targeting polymeric nanoparticles with or without drug.
Lee BS; Park K; Park S; Kim GC; Kim HJ; Lee S; Kil H; Oh SJ; Chi D; Kim K; Choi K; Kwon IC; Kim SY
J Control Release; 2010 Oct; 147(2):253-60. PubMed ID: 20624433
[TBL] [Abstract][Full Text] [Related]
18. Formation and characterization of polyelectrolyte complex synthesized by chitosan and carboxylic curdlan for 5-fluorouracil delivery.
Yan JK; Qiu WY; Wang YY; Wu LX; Cheung PCK
Int J Biol Macromol; 2018 Feb; 107(Pt A):397-405. PubMed ID: 28882758
[TBL] [Abstract][Full Text] [Related]
19. Heparin-deoxycholic acid chemical conjugate as an anticancer drug carrier and its antitumor activity.
Park K; Lee GY; Kim YS; Yu M; Park RW; Kim IS; Kim SY; Byun Y
J Control Release; 2006 Sep; 114(3):300-6. PubMed ID: 16884806
[TBL] [Abstract][Full Text] [Related]
20. Design and evaluation of a novel potential carrier for a hydrophilic antitumor drug: Auricularia auricular polysaccharide-chitosan nanoparticles as a delivery system for doxorubicin hydrochloride.
Xiong W; Li L; Wang Y; Yu Y; Wang S; Gao Y; Liang Y; Zhang G; Pan W; Yang X
Int J Pharm; 2016 Sep; 511(1):267-275. PubMed ID: 27424168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]